drugset / Trial / NCT00212030

Japan-Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by a K-ATP

NCT00212030

RandomizedParallel-groupOpen-labelTreatment

Summary

To evaluate whether nicorandil as an adjunctive therapy for AMI reduces myocardial infarct size and improves regional wall motion

Timeline

Start
2001-10
Primary completion
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nicorandil Other / unclassified 1.67 ug/kg Intravenous